Trial · NCT01510769
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Subjects With a Serum Urate (sUA) Level That is < 5.0 mg/dL by Month 6 | Lesinurad 200 mg + Febuxostat 80 mg | 0.566 | Proportion of Subjects | ||
| Subjects With a Serum Urate (sUA) Level That is < 5.0 mg/dL by Month 6 | Lesinurad 400 mg + Febuxostat 80 mg | 0.761 | Proportion of Subjects | ||
| Subjects With a Serum Urate (sUA) Level That is < 5.0 mg/dL by Month 6 | Placebo + Febuxostat 80 mg | 0.468 | Proportion of Subjects | ||
| Complete Resolution of at Least One Target Tophus | Lesinurad 200 mg + Febuxostat 80 mg | 0.255 | Proportion of Subjects | ||
| Complete Resolution of at Least One Target Tophus | Lesinurad 400 mg + Febuxostat 80 mg | 0.303 | Proportion of Subjects | ||
| Complete Resolution of at Least One Target Tophus | Placebo + Febuxostat 80 mg | 0.211 | Proportion of Subjects | ||
| Complete or Partial Response of at Least One Tophus | Lesinurad 200 mg + Febuxostat 80 mg | 0.566 | Proportion of Subjects | ||
| Complete or Partial Response of at Least One Tophus | Lesinurad 400 mg + Febuxostat 80 mg | 0.587 | Proportion of Subjects | ||
| Complete or Partial Response of at Least One Tophus | Placebo + Febuxostat 80 mg | 0.505 | Proportion of Subjects | ||
| Quality of Life | Lesinurad 200 mg + Febuxostat 80 mg | 0.442 | Proportion of Subjects | ||
| Quality of Life | Lesinurad 400 mg + Febuxostat 80 mg | 0.333 | Proportion of Subjects | ||
| Quality of Life | Placebo + Febuxostat 80 mg | 0.525 | Proportion of Subjects |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01510769/results